Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Rigel Pharmaceuticals
Business Segments
Products & Services
Government contracts revenue
Government contracts revenue
Rigel Pharmaceuticals
·
Products & Services
·
1 segment
·
Rolls up to
Government Assistance Operating Income
Breakdown
Segments
fostamatinib
View metric
Annual
Segment
FY'25
fostamatinib
$300K
Total
—
All segment values are derived from annual filings.
